Equities

Althea Group Holdings Ltd

AGH:ASX

Althea Group Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.03
  • Today's Change0.002 / 7.14%
  • Shares traded2.41m
  • 1 Year change-14.29%
  • Beta1.8269
Data delayed at least 20 minutes, as of Sep 20 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of AUD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments0.333.876.21
Total Receivables, Net4.864.136.31
Total Inventory3.986.203.82
Prepaid expenses1.711.511.45
Other current assets, total------
Total current assets111618
Property, plant & equipment, net121419
Goodwill, net01818
Intangibles, net0.510.901.58
Long term investments0.700.420.33
Note receivable - long term------
Other long term assets------
Total assets244857
LIABILITIES
Accounts payable117.505.41
Accrued expenses0.390.480.52
Notes payable/short-term debt0.9700
Current portion long-term debt/capital leases0.330.190.14
Other current liabilities, total3.758.753.71
Total current liabilities17179.77
Total long term debt5.240.795.00
Total debt6.540.975.14
Deferred income tax------
Minority interest------
Other liabilities, total1.200.860.35
Total liabilities231915
SHAREHOLDERS EQUITY
Common stock868582
Additional paid-in capital------
Retained earnings (accumulated deficit)(86)(54)(41)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.18)(1.42)0.06
Total equity0.313041
Total liabilities & shareholders' equity244857
Total common shares outstanding407381316
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.